Bacterial bioactive metabolites as therapeutic agents: From production to action

Simple item page
dc.contributor.authorK.B. Arun
dc.contributor.authorRaveendran Sindhu
dc.contributor.authorDeepthy Alex
dc.contributor.authorParameswaran Binod
dc.contributor.authorArivalagan Pughazhendi
dc.contributor.authorToms C. Joseph
dc.contributor.authorAshok Pandey
dc.contributor.authorMohammed Kuddus
dc.contributor.authorSanthosh Kumar Pillai
dc.contributor.authorShibitha Emmanual
dc.contributor.authorMukesh Kumar Awasthi
dc.contributor.authorAravind Madhavan
dc.date.accessioned2026-06-19T06:39:55Z
dc.date.available2026-06-19T06:39:55Z
dc.date.issued2022-03-12
dc.description.abstractBacterial metabolites are one of the primary sources of drugs that we currently use to treat several diseases. However, bacterial drug discovery and development is a challenging and time-consuming process, and the emergence of new diseases and the development of resistance to currently available drugs demand the discovery of new metabolites with better biological activities. The new advancements in microbial technology, omics, genome and metabolic engineering, synthetic biology and the interdisciplinary approach of these fields overcome the hurdles in drug discovery and heterologous synthesis from bacteria. The gut microbiome performs a vital role in sustaining human health and aids in tackling various diseases. The metabolites produced by the gut microbiome act as an energy source for colon epithelium, maintain pH, help in cell differentiation and induces apoptosis in abnormal cells. The review discusses about the bacterial derived bioactive compounds, advancements and technologies in bacterial synthesis of bioactive sources and genomic and synthetic biology methods for the bioprospecting of bacterial metabolites. Since the gut microbiome relates to colon health, we have also discussed the techniques comprising probiotics, prebiotics, microbiome transplantation, toxins, and bacteriocins capable of preventing and managing colon associated health condition. Future directions in bacterial bioactive metabolite production are also discussed.
dc.identifier.citationhttps://doi.org/10.1016/j.scp.2022.100650
dc.identifier.urihttps://drs.cift.res.in/123456789/6770
dc.language.isoen
dc.publisherElsevier
dc.subjectResearch Subject Categories::MEDICINE::Microbiology, immunology, infectious diseases::Microbiology
dc.subjectResearch Subject Categories::MEDICINE::Microbiology, immunology, infectious diseases::Microbiology::Bacteriology
dc.titleBacterial bioactive metabolites as therapeutic agents: From production to action
dc.typeArticle
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Peer Reviewed Journal Articles (Inter.) (M,F&B)